Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
tRNA methyltransferase subunit 11-2 pseudogene 3 (TRMT112P3) denotes a region of DNA that closely resembles the functional TRMT112 gene but does not encode a functional protein[3][4]. Pseudogenes are generally nonfunctional and result from duplication or retrotransposition of functional genes; they lack biological activity, are not therapeutic targets, and have no known disease relevance or druggability. Any reference to TRMT112P3 as a target for therapy or biomarker development is incorrect[3][4]. Only the active TRMT112 gene (not TRMT112P3) is involved in protein and RNA methylation, and is associated with some diseases[5][1].
none
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on tRNA methyltransferase subunit 11-2 pseudogene 3 (TRMT112P3).